Two SCF fellows were recently published in the May 1, 2011 edition of Clinical Cancer Research. Koichi Nishijo and Jinu Abraham co-authored the study of IL-4 Receptor as a therapeutic target in rhabdomyosarcoma. We are so proud of the research that our fellows continue to do each year. You can view this publication online.
The Scott Carter Foundation has funded a study in which researchers at Oregon Health & Science University, Doernbecher Children’s Hospital have defined the cell-of-origin for rhabdomyosarcoma, or muscle cancer. Dr. Charles Keller, whose fellowship was funded by The Scott Carter Foundation, was the principal investigator of the study. Read the Cure Search Spring Newsletter to learn more!
Also included in the spring newsletter is a spotlight article on Dr. Keller. Dr. Keller is a huge proponent of children’s cancer research and a friend to The Scott Carter Foundation. You can learn more about his research here.